z-logo
open-access-imgOpen Access
Vorinostat-loaded titanium oxide nanoparticles (anatase) induce G2/M cell cycle arrest in breast cancer cells via PALB2 upregulation
Author(s) -
Shaimaa Abdel-Ghany,
Sara Raslan,
Hüseyin Tombuloğlu,
Aly Shamseddin,
Emre Cevik,
Osama A. M. Said,
Engy F. Madyan,
Mehmet Şenel,
Ayhan Bozkurt,
Suriya Rehman,
Hussein Sabit
Publication year - 2020
Publication title -
3 biotech
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 0.557
H-Index - 37
eISSN - 2190-572X
pISSN - 2190-5738
DOI - 10.1007/s13205-020-02391-2
Subject(s) - vorinostat , cancer research , breast cancer , cancer cell , pancreatic cancer , histone deacetylase inhibitor , cancer , chemistry , erlotinib , apoptosis , medicine , pharmacology , histone deacetylase , epidermal growth factor receptor , histone , biochemistry , gene

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom